{
  "id": "map_1815",
  "title": "HTA ORIGEN\\NENDOCRINO",
  "specialty": "Cardiolog√≠a",
  "tag": "üìã Gu√≠a Cl√≠nica",
  "node_count": 403,
  "root": {
    "text": "HTA ORIGEN\\NENDOCRINO",
    "children": [
      {
        "text": "EPIDEMIOLOG√çA",
        "children": [
          {
            "text": "‚Ä¢ Poblaci√≥n adulta ‚Üí 26% presenta HTA ",
            "children": []
          },
          {
            "text": "‚Ä¢ HTA resistente ‚Üí\\N2-35% hipertensos",
            "children": [
              {
                "text": "‚Üí PA>140/90 pob.general",
                "children": []
              },
              {
                "text": "‚Üí PA>130/80 DM/IRC",
                "children": []
              },
              {
                "text": "‚Üí ‚â•3 antihipertensivos + diur√©tico",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä¢ Meta PA<140/90 ‚Üí solo 45-81% alcanza",
            "children": []
          }
        ]
      },
      {
        "text": "CAUSAS\\NPRINCIPALES",
        "children": [
          {
            "text": "1. Hiperaldosteronismo 1¬∫ (HAP)",
            "children": []
          },
          {
            "text": "2. Exceso mineralocorticoides",
            "children": []
          },
          {
            "text": "3. Menos frecuentes:",
            "children": [
              {
                "text": "‚Üí S.Cushing",
                "children": []
              },
              {
                "text": "‚Üí Acromegalia",
                "children": []
              },
              {
                "text": "‚Üí Hiperparatiroidismo 1¬∫",
                "children": []
              },
              {
                "text": "‚Üí Hipertiroidismo",
                "children": []
              },
              {
                "text": "‚Üí Hipotiroidismo",
                "children": []
              },
              {
                "text": "‚Üí Feocromocitoma",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "HIPERALDOSTERONISMO 1¬∫\\N(HAP)",
        "children": [
          {
            "text": "CARACTER√çSTICAS:",
            "children": [
              {
                "text": "‚Üí Dx precoz importante x > morbimortalidad CV vs HTA esencial",
                "children": []
              },
              {
                "text": "‚Ä¢ Aldosterona ‚Üë aut√≥noma",
                "children": []
              },
              {
                "text": "‚Ä¢ No supresible x Na+",
                "children": []
              },
              {
                "text": "‚Ä¢ Hipokalemia: 9-37% casos (7)",
                "children": []
              },
              {
                "text": "‚Ä¢ Prevalencia: >10% hipertensos (7)",
                "children": [
                  {
                    "text": "‚Ä¢ Adenomas productores ‚Üí 50% casos",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ HAP idiop√°tico ‚Üí 17% casos",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "ETIOLOG√çA\\NHAP (7):",
            "children": [
              {
                "text": "1. APA (adenoma productor aldosterona) ‚Üí 30-35%",
                "children": []
              },
              {
                "text": "2. IHA (hiperaldosteronismo idiop√°tico) ‚Üí 60-70%",
                "children": []
              },
              {
                "text": "3. HPU (hiperplasia suprarrenal uni/bilateral)",
                "children": []
              },
              {
                "text": "HIPERALDOSTERONISMO\\NFAMILIAR (HF)",
                "children": [
                  {
                    "text": "‚Ä¢ Tipo I ‚Üí remediable x glucocorticoides (GRA)",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Tipo II y III ‚Üí reci√©n descritos",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "EVALUACI√ìN\\NBIOQU√çMICA HAP",
            "children": [
              {
                "text": "INDICACIONES\\NTAMIZAJE:",
                "children": [
                  {
                    "text": "1. HTA moderada-grave",
                    "children": []
                  },
                  {
                    "text": "2. HTA resistente ‚Üí PA>140/90 + 3 antihipertensivos",
                    "children": []
                  },
                  {
                    "text": "3. HTA + hipokalemia (espont√°nea/x diur√©ticos)",
                    "children": []
                  },
                  {
                    "text": "4. HTA + incidentaloma suprarrenal",
                    "children": []
                  },
                  {
                    "text": "5. HTA familiar/AVE <40 a√±os",
                    "children": []
                  },
                  {
                    "text": "6. Familiares 1¬∫ grado pacientes HAP",
                    "children": []
                  }
                ]
              },
              {
                "text": "TEST\\NTAMIZAJE:",
                "children": [
                  {
                    "text": "ARR (Aldosterone\\Nto Renin Ratio)",
                    "children": [
                      {
                        "text": "‚Ä¢ Condiciones:",
                        "children": [
                          {
                            "text": "‚Üí Ayuno + reposo 30min",
                            "children": []
                          },
                          {
                            "text": "‚Üí 9am sentado",
                            "children": []
                          }
                        ]
                      },
                      {
                        "text": "‚Ä¢ Valores sospecha:",
                        "children": [
                          {
                            "text": "‚Üí ARR >25 + aldosterona >10 ng/dL",
                            "children": []
                          },
                          {
                            "text": "‚Üí Si ARP suprimida ‚Üí usar 0.3 ng/mL/h",
                            "children": []
                          }
                        ]
                      },
                      {
                        "text": "PREPARACI√ìN\\NTEST:",
                        "children": [
                          {
                            "text": "1. Corregir hipokalemia",
                            "children": []
                          },
                          {
                            "text": "2. Dieta libre Na+",
                            "children": []
                          },
                          {
                            "text": "3. Suspender f√°rmacos interferentes (‚â•2sem)",
                            "children": []
                          },
                          {
                            "text": "4. Cambiar a antihipertensivos m√≠nima interferencia",
                            "children": []
                          }
                        ]
                      },
                      {
                        "text": "F√ÅRMACOS A\\NSUSPENDER:",
                        "children": [
                          {
                            "text": "FALSOS NEGATIVOS\\NARR:",
                            "children": [
                              {
                                "text": "‚Ä¢ Ahorradores de K",
                                "children": [
                                  {
                                    "text": "‚Ä¢ Triamterene",
                                    "children": []
                                  },
                                  {
                                    "text": "‚Ä¢ Amiloride",
                                    "children": []
                                  },
                                  {
                                    "text": "‚Ä¢ Espironolactona",
                                    "children": []
                                  }
                                ]
                              },
                              {
                                "text": "‚Ä¢ Diur√©ticos K+",
                                "children": [
                                  {
                                    "text": "‚Ä¢ Tiazidas",
                                    "children": []
                                  },
                                  {
                                    "text": "Furosemida",
                                    "children": []
                                  }
                                ]
                              },
                              {
                                "text": "‚Ä¢ Anticonceptivos",
                                "children": []
                              },
                              {
                                "text": "‚Ä¢ BCC dihidropirid√≠nicos",
                                "children": []
                              },
                              {
                                "text": "‚Ä¢ IECA",
                                "children": []
                              },
                              {
                                "text": "‚Ä¢ ARA II",
                                "children": []
                              }
                            ]
                          },
                          {
                            "text": "FALSOS POSITIVOS\\NARR:",
                            "children": [
                              {
                                "text": "‚Ä¢ Clonidina",
                                "children": []
                              },
                              {
                                "text": "‚Ä¢ Inhibidores renina",
                                "children": [
                                  {
                                    "text": "‚Ä¢ Aliskireno (cuando renina = actividad plasm√°tica)",
                                    "children": []
                                  }
                                ]
                              },
                              {
                                "text": "‚Ä¢ Œ≤-bloqueadores",
                                "children": []
                              }
                            ]
                          }
                        ]
                      },
                      {
                        "text": "ANTIHIPERTENSIVOS\\NPERMITIDOS:",
                        "children": [
                          {
                            "text": "1. Verapamilo LP ‚Üí 90-120mg/12h",
                            "children": []
                          },
                          {
                            "text": "2. Hidralazina ‚Üí 10-12.5mg/12h",
                            "children": []
                          },
                          {
                            "text": "3. Prazosina ‚Üí 0.5-1mg/12h",
                            "children": []
                          },
                          {
                            "text": "4. Doxazosina ‚Üí 1-2mg/24h",
                            "children": []
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "text": "CONFIRMACI√ìN\\NBIOQU√çMICA HAP",
                "children": [
                  {
                    "text": "INDICACI√ìN:",
                    "children": [
                      {
                        "text": "‚Üí Renina plasm√°tica aumentada",
                        "children": []
                      },
                      {
                        "text": "‚Üí Evita ex√°menes riesgosos innecesarios",
                        "children": []
                      },
                      {
                        "text": "‚Üí ARR >25 ‚Üí test confirmatorio obligatorio",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "SELECCI√ìN TEST:",
                    "children": [
                      {
                        "text": "‚Ä¢ Sin evidencia suficiente para recomendar uno espec√≠fico",
                        "children": []
                      },
                      {
                        "text": "‚Ä¢ Considerar:",
                        "children": [
                          {
                            "text": "‚Üí Costos",
                            "children": []
                          },
                          {
                            "text": "‚Üí Cumplimiento paciente",
                            "children": []
                          },
                          {
                            "text": "‚Üí Laboratorio disponible",
                            "children": []
                          },
                          {
                            "text": "‚Üí Experiencia local",
                            "children": []
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "text": "TESTS\\NCONFIRMATORIOS:",
                    "children": [
                      {
                        "text": "1. Sobrecarga salina IV:",
                        "children": [
                          {
                            "text": "‚Üí Simple + r√°pido",
                            "children": []
                          },
                          {
                            "text": "‚Üí No requiere orina",
                            "children": []
                          },
                          {
                            "text": "‚Üí 2L SF 0.9% en 4h",
                            "children": []
                          },
                          {
                            "text": "‚Üí Aldosterona: 9am pre/post",
                            "children": []
                          },
                          {
                            "text": "‚Üí (+) si aldosterona post >5 ng/dL",
                            "children": []
                          },
                          {
                            "text": "‚Üí M√°s usado",
                            "children": []
                          }
                        ]
                      },
                      {
                        "text": "2. Supresi√≥n\\Nfludrocortisona:",
                        "children": [
                          {
                            "text": "‚Üí 0.1mg/6h x 4 d√≠as",
                            "children": []
                          },
                          {
                            "text": "‚Üí Aldosterona d√≠a 5 a 9am",
                            "children": []
                          },
                          {
                            "text": "‚Üí (+) si >5 ng/dL",
                            "children": []
                          }
                        ]
                      },
                      {
                        "text": "3. Sobrecarga\\Noral Na+:",
                        "children": [
                          {
                            "text": "‚Üí Requiere orina",
                            "children": []
                          },
                          {
                            "text": "‚Üí NaCl 6g/d√≠a x 3 d√≠as + K+",
                            "children": []
                          },
                          {
                            "text": "‚Üí (+) si:",
                            "children": [
                              {
                                "text": "‚Ä¢ Aldosterona urinaria >12 ¬µg/24h",
                                "children": []
                              },
                              {
                                "text": "‚Ä¢ Na+ urinario >200 mEq/24h",
                                "children": []
                              }
                            ]
                          }
                        ]
                      },
                      {
                        "text": "4. Test captopril:",
                        "children": [
                          {
                            "text": "‚Üí Posici√≥n sentada 60min",
                            "children": []
                          },
                          {
                            "text": "‚Üí 25mg captopril oral 9am",
                            "children": []
                          },
                          {
                            "text": "‚Üí Medir a 2h:",
                            "children": [
                              {
                                "text": "‚Ä¢ Aldosterona plasm√°tica",
                                "children": []
                              },
                              {
                                "text": "‚Ä¢ ARP",
                                "children": []
                              }
                            ]
                          },
                          {
                            "text": "‚Üí (+) si:",
                            "children": [
                              {
                                "text": "‚Ä¢ ARR >30 o",
                                "children": []
                              },
                              {
                                "text": "‚Ä¢ Aldosterona >8.5 ng/dL",
                                "children": []
                              }
                            ]
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "text": "PRECAUCIONES\\NTESTS:",
                    "children": [
                      {
                        "text": "‚Ä¢ Fludrocortisona/salina IV:",
                        "children": [
                          {
                            "text": "‚Üí Contraindicados: HTA no controlada/ICC",
                            "children": []
                          }
                        ]
                      },
                      {
                        "text": "‚Ä¢ Captopril:",
                        "children": [
                          {
                            "text": "‚Üí Preferible si riesgo sobrecarga volumen",
                            "children": []
                          }
                        ]
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "ALGORITMO\\NESTUDIO HAP:",
            "children": [
              {
                "text": "1. HTA alta probabilidad HAP",
                "children": []
              },
              {
                "text": "2. Medir ARR",
                "children": [
                  {
                    "text": "‚Üí <25 ‚Üí HAP improbable",
                    "children": []
                  },
                  {
                    "text": "‚Üí >25 ‚Üí Test confirmatorio",
                    "children": []
                  }
                ]
              },
              {
                "text": "3. Si (+) ‚Üí TAC abdomen",
                "children": []
              },
              {
                "text": "4. Seg√∫n hallazgos:",
                "children": [
                  {
                    "text": "‚Üí Unilateral ‚Üí Suprarrenalectom√≠a laparosc√≥pica",
                    "children": []
                  },
                  {
                    "text": "‚Üí Bilateral ‚Üí Antagonistas mineralocorticoides",
                    "children": []
                  }
                ]
              },
              {
                "text": "5. Resultado ‚Üí Determina subtipo",
                "children": []
              },
              {
                "text": "CLASIFICACI√ìN\\NSUBTIPO HAP",
                "children": []
              }
            ]
          },
          {
            "text": "EX√ÅMENES\\NFUNDAMENTALES:",
            "children": [
              {
                "text": "1. TAC abdomen:",
                "children": [
                  {
                    "text": "‚Üí Obligatorio si HAP confirmado",
                    "children": []
                  },
                  {
                    "text": "‚Üí APA: n√≥dulo <2cm",
                    "children": []
                  },
                  {
                    "text": "‚Üí IHA: gl√°ndulas normales/‚Üëbilateral",
                    "children": []
                  },
                  {
                    "text": "‚Üí Carcinomas: >4cm",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Limitaciones (7):",
                    "children": [
                      {
                        "text": "‚Üí APA peque√±os",
                        "children": []
                      },
                      {
                        "text": "‚Üí IHA falso",
                        "children": []
                      },
                      {
                        "text": "‚Üí Adenomas no funcionantes",
                        "children": []
                      },
                      {
                        "text": "‚Üí Exactitud 53%",
                        "children": []
                      },
                      {
                        "text": "‚Üí RM sin ventajas vs TAC",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "2. MVS (muestreo\\Nvenas suprarrenales):",
                "children": [
                  {
                    "text": "‚Üí Indicado pre-cirug√≠a",
                    "children": []
                  },
                  {
                    "text": "‚Üí Gold standard lateralizaci√≥n",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Caracter√≠sticas (7):",
                    "children": [
                      {
                        "text": "‚Üí Sensibilidad 95%",
                        "children": []
                      },
                      {
                        "text": "‚Üí Especificidad 100%",
                        "children": []
                      },
                      {
                        "text": "‚Üí Complicaciones 2.5%",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ T√©cnica:",
                    "children": [
                      {
                        "text": "‚Üí Mide aldosterona/cortisol bilateral",
                        "children": []
                      },
                      {
                        "text": "‚Üí √âxito: cortisol vena/cava >2",
                        "children": []
                      },
                      {
                        "text": "‚Üí Lateralizaci√≥n (+): ratio >4",
                        "children": []
                      },
                      {
                        "text": "‚Üí Bajo ACTH",
                        "children": []
                      },
                      {
                        "text": "‚Üí Dificultad canulaci√≥n vena derecha",
                        "children": []
                      },
                      {
                        "text": "‚Üí Solo centros experimentados",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "CLASIFICACI√ìN\\NHAP FAMILIAR",
            "children": [
              {
                "text": "HAP FAMILIAR (HF):",
                "children": [
                  {
                    "text": "1. TIPO I (HF-I):",
                    "children": [
                      {
                        "text": "‚Üí Test gen√©tico: CYP11B1/CYP11B2 (XL-PCR)",
                        "children": []
                      },
                      {
                        "text": "‚Üí Indicaciones:",
                        "children": [
                          {
                            "text": "‚Ä¢ Pacientes HF-I",
                            "children": []
                          },
                          {
                            "text": "‚Ä¢ HTA temprana",
                            "children": []
                          },
                          {
                            "text": "‚Ä¢ Historia familiar HTA + ACV",
                            "children": []
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "text": "2. TIPO II:",
                    "children": [
                      {
                        "text": "‚Üí HAP confirmado ‚â•2 familiares",
                        "children": []
                      },
                      {
                        "text": "‚Üí Excluir HF-I (test gen√©tico -)",
                        "children": []
                      },
                      {
                        "text": "‚Üí Gen√©tica no aclarada",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "TRATAMIENTO\\NSEG√öN SUBTIPO",
            "children": [
              {
                "text": "1. APA + HP:",
                "children": [
                  {
                    "text": "‚Üí Suprarrenalectom√≠a laparosc√≥pica (8)",
                    "children": []
                  },
                  {
                    "text": "‚Üí Control electrolitos 15 d√≠as post-cx",
                    "children": []
                  }
                ]
              },
              {
                "text": "2. IHA:",
                "children": [
                  {
                    "text": "‚Üí Espironolactona 25-200mg/d√≠a",
                    "children": []
                  },
                  {
                    "text": "‚Üí Alternativa: eplerenona 25-100mg/d√≠a",
                    "children": []
                  }
                ]
              },
              {
                "text": "3. HF tipo I:",
                "children": [
                  {
                    "text": "‚Üí Dexametasona 0. 125-0.5mg nocturna",
                    "children": []
                  },
                  {
                    "text": "‚Üí Dosis m√≠nima efectiva",
                    "children": []
                  },
                  {
                    "text": "‚Üí ¬± espironolactona seg√∫n respuesta",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "SEAM (S.Exceso Aparente\\NMineralocorticoide)",
        "children": [
          {
            "text": "CARACTER√çSTICAS:",
            "children": [
              {
                "text": "‚Ä¢ Gen√©tica: autos√≥mica recesiva",
                "children": []
              },
              {
                "text": "‚Ä¢ D√©ficit 11Œ≤-HSD2",
                "children": []
              },
              {
                "text": "‚Ä¢ Cortisol ‚Üí cortisona (ri√±√≥n)",
                "children": []
              },
              {
                "text": "‚Ä¢ D√©ficit ‚Üí cortisol activa receptor mineralocorticoide",
                "children": []
              }
            ]
          },
          {
            "text": "EPIDEMIOLOG√çA:",
            "children": [
              {
                "text": "‚Ä¢ 15.7% hipertensos esenciales (9)",
                "children": []
              },
              {
                "text": "‚Ä¢ Presentaci√≥n:",
                "children": [
                  {
                    "text": "‚Üí Ni√±ez: grave",
                    "children": []
                  },
                  {
                    "text": "‚Üí Adultez: leve",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Gravedad ‚àù actividad 11Œ≤-HSD2",
                "children": []
              }
            ]
          },
          {
            "text": "CL√çNICA:",
            "children": [
              {
                "text": "‚Ä¢ Hipokalemia",
                "children": []
              },
              {
                "text": "‚Ä¢ Diabetes ins√≠pida",
                "children": []
              },
              {
                "text": "‚Ä¢ Nefrocalcinosis",
                "children": []
              },
              {
                "text": "‚Ä¢ HTA",
                "children": []
              },
              {
                "text": "‚Ä¢ Retraso crecimiento (ni√±os)",
                "children": []
              }
            ]
          },
          {
            "text": "DIAGN√ìSTICO:",
            "children": [
              {
                "text": "‚Ä¢ ARP <1 ng/mL/h",
                "children": []
              },
              {
                "text": "‚Ä¢ Aldosterona <5 ng/dL",
                "children": []
              },
              {
                "text": "‚Ä¢ Ratio cortisol/cortisona urinaria ‚Üë",
                "children": [
                  {
                    "text": "‚Üí Normal: 0.2-0.5",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "F√ÅRMACOS:",
            "children": [
              {
                "text": "1. Espironolactona y/o\\Ndexametasona",
                "children": [
                  {
                    "text": "‚Üí Suprime cortisol end√≥geno",
                    "children": []
                  },
                  {
                    "text": "‚Üí Sin efecto mineralocorticoide propio",
                    "children": []
                  }
                ]
              },
              {
                "text": "2. Alternativas:",
                "children": [
                  {
                    "text": "‚Üí Amiloride",
                    "children": []
                  },
                  {
                    "text": "‚Üí Tiazidas",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Beneficio adicional: ‚Üìhipercalciuria",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "S.LIDDLE",
        "children": [
          {
            "text": "FISIOPATOLOG√çA:",
            "children": [
              {
                "text": "‚Ä¢ Autos√≥mico dominante",
                "children": []
              },
              {
                "text": "‚Ä¢ Mutaci√≥n ENaC t√∫bulo colector renal",
                "children": []
              },
              {
                "text": "‚Ä¢ ‚Üëcanales Na+ funcionantes",
                "children": []
              },
              {
                "text": "‚Ä¢ ‚Üëreabsorci√≥n Na+/H2O ‚Üí HTA",
                "children": []
              }
            ]
          },
          {
            "text": "CL√çNICA:",
            "children": [
              {
                "text": "‚Ä¢ HTA grave",
                "children": []
              },
              {
                "text": "‚Ä¢ Hipokalemia + alcalosis metab√≥lica",
                "children": []
              },
              {
                "text": "‚Ä¢ ARP/aldosterona ‚Üì",
                "children": []
              },
              {
                "text": "‚Ä¢ No responde espironolactona\\N(act√∫a receptor, no ENaC)",
                "children": []
              }
            ]
          },
          {
            "text": "TRATAMIENTO:",
            "children": [
              {
                "text": "‚Ä¢ Dieta Na+ <2g/d√≠a",
                "children": []
              },
              {
                "text": "‚Ä¢ Inhibidores ENaC:",
                "children": [
                  {
                    "text": "‚Üí Amiloride",
                    "children": []
                  },
                  {
                    "text": "‚Üí Triamterene",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "FEOCROMOCITOMA",
        "children": [
          {
            "text": "CARACTER√çSTICAS:",
            "children": [
              {
                "text": "‚Ä¢ Neoplasia productora catecolaminas",
                "children": []
              },
              {
                "text": "‚Ä¢ Origen:",
                "children": [
                  {
                    "text": "‚Üí M√©dula suprarrenal (85%)",
                    "children": []
                  },
                  {
                    "text": "‚Üí Ganglios SNS (15%)",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Epidemiolog√≠a:",
                "children": [
                  {
                    "text": "‚Üí Incidencia: 1-2/100.000/a√±o",
                    "children": []
                  },
                  {
                    "text": "‚Üí 0.2% hipertensos",
                    "children": []
                  },
                  {
                    "text": "‚Üí 10% hallazgo incidental TAC/RM (10)",
                    "children": []
                  },
                  {
                    "text": "‚Üí 15-20% familiares",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "SOSPECHA DX:",
            "children": [
              {
                "text": "1. Cl√≠nica + s√≠ntomas",
                "children": []
              },
              {
                "text": "2. Masa suprarrenal incidental",
                "children": []
              },
              {
                "text": "3. Historia familiar/s√≠ndrome gen√©tico",
                "children": []
              }
            ]
          },
          {
            "text": "CL√çNICA:",
            "children": [
              {
                "text": "‚Ä¢ Tr√≠ada cl√°sica:",
                "children": [
                  {
                    "text": "‚Üí Cefalea",
                    "children": []
                  },
                  {
                    "text": "‚Üí Sudoraci√≥n",
                    "children": []
                  },
                  {
                    "text": "‚Üí Taquicardia",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ Otros:",
                "children": [
                  {
                    "text": "‚Üí HTA parox√≠stica (48%)",
                    "children": []
                  },
                  {
                    "text": "‚Üí HTA sostenida (29%)",
                    "children": []
                  },
                  {
                    "text": "‚Üí Ansiedad",
                    "children": []
                  },
                  {
                    "text": "‚Üí Temblor",
                    "children": []
                  },
                  {
                    "text": "‚Üí Parestesias",
                    "children": []
                  }
                ]
              },
              {
                "text": "‚Ä¢ 8% asintom√°ticos",
                "children": []
              },
              {
                "text": "‚Ä¢ 13% normotensos",
                "children": []
              }
            ]
          },
          {
            "text": "DIAGN√ìSTICO:",
            "children": [
              {
                "text": "Metanefrinas:",
                "children": [
                  {
                    "text": "‚Üí Plasma: sensibilidad 99%",
                    "children": []
                  },
                  {
                    "text": "‚Üí Orina 24h fraccionada: sensibilidad 97%",
                    "children": []
                  }
                ]
              },
              {
                "text": "LOCALIZACI√ìN:",
                "children": [
                  {
                    "text": "‚Ä¢ Tumores:",
                    "children": [
                      {
                        "text": "‚Üí 95% abdominop√©lvicos",
                        "children": []
                      },
                      {
                        "text": "‚Üí 85% suprarrenales",
                        "children": []
                      },
                      {
                        "text": "‚Üí 15% extrasuprarrenales",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "‚Ä¢ Extrasuprarrenales:",
                    "children": [
                      {
                        "text": "‚Üí 75% para√≥rticos abdominales",
                        "children": []
                      },
                      {
                        "text": "‚Üí 10% vejiga",
                        "children": []
                      },
                      {
                        "text": "‚Üí 10% t√≥rax",
                        "children": []
                      },
                      {
                        "text": "‚Üí 5% cabeza/cuello/pelvis",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "ESTUDIOS\\NIMAGEN:",
                    "children": [
                      {
                        "text": "1. TAC/RM abdomen-pelvis:",
                        "children": [
                          {
                            "text": "‚Üí Sensibilidad: 98-100%",
                            "children": []
                          },
                          {
                            "text": "‚Üí Especificidad: 70-80%",
                            "children": []
                          },
                          {
                            "text": "‚Üí RM: tumor hiperintenso T2",
                            "children": []
                          }
                        ]
                      },
                      {
                        "text": "2. Cintigrama MIBG:",
                        "children": [
                          {
                            "text": "‚Üí Sensibilidad: 90-95%",
                            "children": []
                          },
                          {
                            "text": "‚Ä¢ Especificidad: 99%",
                            "children": []
                          },
                          {
                            "text": "‚Ä¢ Indicaciones:",
                            "children": [
                              {
                                "text": "‚Üí Tumores >5cm",
                                "children": []
                              },
                              {
                                "text": "‚Üí Paragangliomas",
                                "children": []
                              },
                              {
                                "text": "‚Üí Sospecha enfermedad multifocal",
                                "children": []
                              }
                            ]
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "text": "CRITERIOS ESTUDIO\\NGEN√âTICO:",
                "children": [
                  {
                    "text": "1. Paragangliomas",
                    "children": []
                  },
                  {
                    "text": "2. Feocromocitoma suprarrenal bilateral",
                    "children": []
                  },
                  {
                    "text": "3. Feocromocitoma unilateral + historia familiar",
                    "children": []
                  },
                  {
                    "text": "4. Feocromocitoma unilateral <40 a√±os\\N+ cl√≠nica sugerente:",
                    "children": [
                      {
                        "text": "‚Üí NEM2",
                        "children": []
                      },
                      {
                        "text": "‚Üí Von Hippel-Lindau",
                        "children": []
                      },
                      {
                        "text": "‚Üí Neurofibromatosis-1",
                        "children": []
                      },
                      {
                        "text": "‚Üí S.paragangliomas",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "INTERFERENCIAS\\NMETANEFRINAS:",
            "children": [
              {
                "text": "ALIMENTOS:",
                "children": [
                  {
                    "text": "‚Ä¢ Caf√©/descafeinado/t√©/mate",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Alcohol",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Bebidas cola",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Chocolate",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Tomates",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Palta",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Berenjenas",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Nueces",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Pl√°tanos",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Queso",
                    "children": []
                  }
                ]
              },
              {
                "text": "MEDICAMENTOS:",
                "children": [
                  {
                    "text": "‚Ä¢ Labetalol",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Sotalol",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Paracetamol",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Levodopa",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Metildopa",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Anfetaminas",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Efedrina",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ ADT",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ IMAO",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Teofilina",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Hidralazina monoterapia",
                    "children": []
                  },
                  {
                    "text": "‚Ä¢ Minoxidil monoterapia",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "TRATAMIENTO\\NPRE-QUIR√öRGICO:",
            "children": [
              {
                "text": "1. EVALUACI√ìN INICIAL:",
                "children": [
                  {
                    "text": "‚Üí Capacidad funcional",
                    "children": []
                  },
                  {
                    "text": "‚Üí ECG",
                    "children": []
                  },
                  {
                    "text": "‚Üí ¬± Ecocardiograma",
                    "children": []
                  }
                ]
              },
              {
                "text": "2. PROTOCOLO\\NFARMACOL√ìGICO:",
                "children": [
                  {
                    "text": "a) Bloqueo Œ±-adren√©rgico:",
                    "children": [
                      {
                        "text": "‚Üí Inicio ‚â•1 semana pre-cx",
                        "children": []
                      },
                      {
                        "text": "‚Üí Objetivo: normalizar PA/FC",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "b) Si no control:",
                    "children": [
                      {
                        "text": "‚Üí A√±adir BCC ‚Üí PA",
                        "children": []
                      },
                      {
                        "text": "‚Üí A√±adir Œ≤-bloqueador ‚Üí FC",
                        "children": []
                      },
                      {
                        "text": "(post bloqueo Œ±)",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "c) D√≠a 3 bloqueo Œ±:",
                    "children": [
                      {
                        "text": "‚Üí Dieta Na+ >5g/d√≠a",
                        "children": []
                      },
                      {
                        "text": "‚Üí Prevenir shock hipovol√©mico post-cx",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "3. PRECAUCIONES:",
                "children": [
                  {
                    "text": "‚Üí ICC",
                    "children": []
                  },
                  {
                    "text": "‚Üí IRC",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "F√ÅRMACOS (11,12):",
            "children": [
              {
                "text": "1. Doxazosina: 1-16mg/d√≠a",
                "children": []
              },
              {
                "text": "2. Post bloqueo Œ±:",
                "children": [
                  {
                    "text": "‚Üí Propanolol 40mg/8h o",
                    "children": []
                  },
                  {
                    "text": "‚Üí Atenolol 25-50mg/d√≠a",
                    "children": []
                  }
                ]
              },
              {
                "text": "3. Amlodipino 5-20mg/d√≠a si HTA persistente",
                "children": []
              }
            ]
          },
          {
            "text": "CONTRAINDICADOS:",
            "children": [
              {
                "text": "‚Ä¢ Labetalol",
                "children": []
              },
              {
                "text": "‚Ä¢ Carvedilol",
                "children": []
              },
              {
                "text": "(Œ±+Œ≤ ‚Üí crisis parad√≥jica/HTA grave)",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "TABLA RESUMEN HTA\\NMINERALOCORTICOIDE",
        "children": [
          {
            "text": "APA (Adenoma\\NProductor Aldosterona):",
            "children": [
              {
                "text": "‚Üí Aldosterona: ‚Üë‚Üë",
                "children": []
              },
              {
                "text": "‚Üí ARP: ‚Üì‚Üì",
                "children": []
              },
              {
                "text": "‚Üí ARR: >25",
                "children": []
              },
              {
                "text": "‚Üí F/E: Normal",
                "children": []
              },
              {
                "text": "‚Üí TAC: N√≥dulo <2cm",
                "children": []
              },
              {
                "text": "‚Üí Bilateral: NO",
                "children": []
              },
              {
                "text": "‚Üí Tratamiento: Suprarrenalectom√≠a",
                "children": []
              }
            ]
          },
          {
            "text": "IHA\\N(Hiperaldosteronismo\\NIdiop√°tico):",
            "children": [
              {
                "text": "‚Üí Aldosterona: ‚Üë",
                "children": []
              },
              {
                "text": "‚Üí ARP: ‚Üì",
                "children": []
              },
              {
                "text": "‚Üí ARR: >25",
                "children": []
              },
              {
                "text": "‚Üí F/E: Normal",
                "children": []
              },
              {
                "text": "‚Üí TAC: Normal/n√≥dulos bilaterales",
                "children": []
              },
              {
                "text": "‚Üí Bilateral: S√ç",
                "children": []
              },
              {
                "text": "‚Üí Tratamiento: Espironolactona",
                "children": []
              }
            ]
          },
          {
            "text": "HP\\N(Hiperplasia\\NPrimaria):",
            "children": [
              {
                "text": "‚Üí Aldosterona: ‚Üë",
                "children": []
              },
              {
                "text": "‚Üí ARP: ‚Üì",
                "children": []
              },
              {
                "text": "‚Üí ARR: >25",
                "children": []
              },
              {
                "text": "‚Üí F/E: Normal",
                "children": []
              },
              {
                "text": "‚Üí TAC: Normal/hiperplasia unilateral",
                "children": []
              },
              {
                "text": "‚Üí Bilateral: NO",
                "children": []
              },
              {
                "text": "‚Üí Tratamiento: Suprarrenalectom√≠a",
                "children": []
              }
            ]
          },
          {
            "text": "HF tipo I:",
            "children": [
              {
                "text": "‚Üí Aldosterona: ‚Üë",
                "children": []
              },
              {
                "text": "‚Üí ARP: ‚Üì",
                "children": []
              },
              {
                "text": "‚Üí ARR: >25",
                "children": []
              },
              {
                "text": "‚Üí F/E: Normal",
                "children": []
              },
              {
                "text": "‚Üí TAC: Normal",
                "children": []
              },
              {
                "text": "‚Üí Bilateral: S√ç",
                "children": []
              },
              {
                "text": "‚Üí Tratamiento: Dexametasona",
                "children": []
              }
            ]
          },
          {
            "text": "SEAM:",
            "children": [
              {
                "text": "‚Ä¢ Aldosterona: ‚Üì",
                "children": []
              },
              {
                "text": "‚Ä¢ ARP: ‚Üì",
                "children": []
              },
              {
                "text": "‚Ä¢ ARR: <25",
                "children": []
              },
              {
                "text": "‚Ä¢ F/E: ‚Üë",
                "children": []
              },
              {
                "text": "‚Ä¢ TAC: normal",
                "children": []
              },
              {
                "text": "‚Ä¢ Bilateral: N/A",
                "children": []
              },
              {
                "text": "‚Ä¢ Tratamiento: espironolactona ¬± dexametasona",
                "children": []
              },
              {
                "text": "‚Ä¢ Alternativas: amiloride/tiazidas (‚Üìhipercalciuria)",
                "children": []
              }
            ]
          },
          {
            "text": "S.LIDDLE:",
            "children": [
              {
                "text": "‚Ä¢ Aldosterona: ‚Üì",
                "children": []
              },
              {
                "text": "‚Ä¢ ARP: ‚Üì",
                "children": []
              },
              {
                "text": "‚Ä¢ ARR: <25",
                "children": []
              },
              {
                "text": "‚Ä¢ F/E: normal",
                "children": []
              },
              {
                "text": "‚Ä¢ TAC: normal",
                "children": []
              },
              {
                "text": "‚Ä¢ Bilateral: N/A",
                "children": []
              },
              {
                "text": "‚Ä¢ Tratamiento: amiloride/triamterene",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "S.CUSHING",
        "children": [
          {
            "text": "CARACTER√çSTICAS:",
            "children": [
              {
                "text": "‚Ä¢ S√≠ntomas/signos exposici√≥n excesiva glucocorticoides",
                "children": []
              },
              {
                "text": "‚Ä¢ HTA en 76% pacientes (13)",
                "children": []
              }
            ]
          },
          {
            "text": "‚Ä¢ Mecanismo:",
            "children": [
              {
                "text": "‚Üí Alta afinidad cortisol-receptor mineralocorticoide",
                "children": []
              },
              {
                "text": "‚Üí [Cortisol] ‚Üë ‚Üí HTA",
                "children": []
              }
            ]
          }
        ]
      }
    ]
  },
  "related_maps": [
    {
      "id": "map_1633",
      "title": "ACV: ESCALAS DE UTILIDAD CL√çNICA"
    },
    {
      "id": "map_1673",
      "title": "DAPA-CKD (2020)\\NDapagliflozin And Prevention\\Nof Adverse outcomes in CKD\\N\\N‚≠ê iSGLT2 protege ri√±√≥n\\NINCLUSO SIN DIABETES\\N(Extiende beneficio a ERC no-DM)"
    },
    {
      "id": "map_1674",
      "title": "CREDENCE (2019)\\NCanagliflozin and Renal Events in Diabetes\\N\\nCanagliflozina reduce progresion ERC\\ny eventos CV en DM2 con nefropatia\\nNNTH 22 para outcome renal"
    },
    {
      "id": "map_1689",
      "title": "SPRINTT (2021)\\NSarcopenia and Physical\\NFragility in Older People:\\NMulti-component Treatment\\N\\n‚≠ê Ejercicio + nutrici√≥n reduce\\ndiscapacidad en fragilidad f√≠sica\\ncon sarcopenia"
    },
    {
      "id": "map_1785",
      "title": "ELDERCARE-AF (2020)\\NEdoxaban Low-Dose for\\NEldeRly patiEnts with\\NAtrial Fibrillation\\N\\n‚≠ê Edoxaban 15mg reduce ACV 66%\\nvs placebo en muy ancianos\\nno candidatos a ACO est√°ndar"
    }
  ],
  "source_file": "Arteaga | Hipertension Endrocrina-2024.smmx",
  "created": "2026-02-07T15:42:58.331107"
}